Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
8 9 Search
2025
Targeting NLRC4 for potential therapeutic strategies in lung adenocarcinoma
Discover Oncology
Xue Xu, Meng-Yu Zhang, Jia-Qi Fan, Guo-Dong Li, Jun-Yi Li, Xiao Chen
2025
Investigate of LOC101928988 Regulatory Effect on the DAPK2 Transcription in Breast Tumors
Cancer Reports
Mohammadreza Saberiyan, Nazila Ghasemi, Negar Jafari, Mahboubeh Sadeghi, Abbas Ghaderi, Pegah Mousavi
2024
The role of DAPK2 as a key regulatory element in various human cancers: a systematic review
Molecular Biology Reports
Mohammadreza Saberiyan, Mahboobeh Zarei, Amir Safi, Parvaneh Movahhed, Reihane Khorasanian, Samaneh Adelian, Pegah Mousavi
2023
Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy
Frontiers in Genetics
Jinsong Wang, Xue Cui, Yiming Weng, Jiayan Wei, Xinyi Chen, Peiwei Wang, Tong Wang, Jian Qin, Min Peng
2023
Integrated Bioinformatics Approach for Disclosing Autophagy Pathway as a Therapeutic Target in Advanced KRAS Mutated/Positive Lung Adenocarcinoma
The Open Bioinformatics Journal
Yasmeen Dodin
2023
A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma
Scientific Reports
Zi Chen, Linyang Ge, Shuanglan Xu, Qin Li, Linfu Zhou
2022
Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma
Frontiers in Immunology
Yuli Wang, Jing Xu, Yuan Fang, Jiefei Gu, Fanchen Zhao, Yu Tang, Rongzhong Xu, Bo Zhang, Jianchun Wu, Zhihong Fang, Yan Li
2021
Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
Frontiers in Genetics
Hang Chen, Zeyang Hu, Menglu Sang, Saiqi Ni, Yao Lin, Chengfang Wu, Yinyu Mu, Kaitai Liu, Shibo Wu, Ni Li, Guodong Xu
Additional cited-by details will be shown when available from Crossref